Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT04849559

Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers

VP-VLY-686-1301: A Single Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying in Healthy Volunteers

Sponsor: Mayo Clinic

Conditions Healthy Volunteer

Interventions Placebo Tradipitant

Updated 5 times since 2021 Last updated: Mar 19, 2024 Started: Feb 1, 2021 Primary completion: Sep 24, 2021 Completion: Sep 24, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04849559, this PHASE1/PHASE2 trial focuses on Healthy Volunteer and remains completed. Sponsored by Mayo Clinic, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
May 2024 — Jul 2024 [monthly]

Completed PHASE1_PHASE2

Status: Unknown Status → Completed · Phase: PHASE1 → PHASE1_PHASE2
May 2023 — May 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Recruiting PHASE1

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
Vanda Pharmaceuticals

Data source: Vanda Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States